| 1 |
Olpin JD, Sjoberg BP, Stilwill SE, et al. Beyond the bowel: extraintestinal manifestations of inflammatory bowel disease[J]. Radiographics, 2017, 37(4): 1135-1160.
|
| 2 |
Papanikolaou I, Kagouridis K, Papiris SA. Patterns of airway involvement in inflammatory bowel diseases[J]. World J Gastrointest Pathophysiol, 2014, 5(4): 560-569.
|
| 3 |
Chew Michael Tsuyoshi, Chak Eric, Matsukuma Karen. A rare cause of pulmonary nodules[J]. Case Rep Gastroenterol, 2016, 10(3): 633-639.
|
| 4 |
Kaur Gagandeep, Olayinka Oluwaseyi, Chacho Mary S, et al. Pulmonary Symptoms as the First Manifestation of Crohn′s Disease[J]. Cureus, 2020, 12(7): e9379.
|
| 5 |
Omori H, Asahi H, Inoue Y, et al. Plumonary involvement in Crohns disease report of a case and review of the literature[J]. Inflamm Bowel Dis, 2004，10(2): 129-134.
|
| 6 |
Lu DG, Ji XQ, Liu X, et al. Pulmonary manifestations of Crohn′s disease[J]. World J Gastroenterol, 2014, 20(1): 133-141.
|
| 7 |
Cozzi D, Moroni C, Addeo G, et al. Radiological patterns of lung involvement in inflammatory bowel disease[J]. Gastroenterol Res Pract, 2018, 2018: 5697846.
|
| 8 |
Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies[J]. Lancet, 2018, 390: 2769-2778.
|
| 9 |
中华医学会消化病学分会炎症性肠病学组．炎症性肠病诊断与治疗的共识意见(2012年·广州)[J]. 中华内科杂志，2012, 51(10): 818-831.
|
| 10 |
Zaman T, Watson J, Zaman M. Cryptogenic organizing pneumonia with lung nodules secondary to pulmonary manifestation of Crohn disease[J]. Clin Med Insights Case Rep, 2017, 10: 1-2.
|
| 11 |
Hsu YC, Wu TC, Lo YC, et al. Gastrointestinal complications and extraintestinal manifestations of inflammatory bowel disease in Taiwan: a population-based study[J]. J Chin Med Assoc, 2017, 80(2): 56-62.
|
| 12 |
Lakatos L, Pandur T, David G, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study[J]. World J Gastroenterol, 2003, 9(10): 2300-2307.
|
| 13 |
Karmiris K, Avgerinos A, Tavernaraki A, et al. Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease[J]. J Crohns Colitis, 2016, 10(4): 429-436.
|
| 14 |
Bandyopadhyay D, Bandyopadhyay S, Ghosh P, et al. Extraintestinal manifestations in inflammatory bowel disease: prevalence and predictors in Indian patients[J]. Indian J Gastroenterol, 2015, 34(5): 387-394.
|
| 15 |
陈俊榕，张 敏，孙家琛，等. 克罗恩病合并肺结节三例报道并文献复习[J]. 中华炎性肠病杂志，2020, 4(3): 223-228.
|
| 16 |
Ramchandar Nanda, Wojtczak Henry A. Pulmonary epithelioid hemangioendothelioma in a patient with Crohn′s disease Case[J]. Rep Pediatr, 2015, 2015: 491960.
|
| 17 |
Nelson BA, Kaplan JL, El Saleeby CM, et al. Case records of the massachusetts general hospital. Case 39 2014. A 9 year old girl with Crohn′s disease and pulmonary nodules[J]. N Engl JMed, 2014, 371(25): 2418-2427.
|
| 18 |
Shin D, Park BK, Seo J, et al. Pulmonary extraintestinal manifestation of Crohn′s disease treated successfully with adalimumab[J]. Korean J Gastroenterol, 2018, 72(3): 141-145.
|
| 19 |
Kraft SC, Earle RH, Roesler M, et al. Unexplained bronchopulmonary disease with inflammatory bowel disease[J]. Arch Intern Med, 1976, 136(4): 454-459.
|
| 20 |
Shin Dongyeol, Park Byung Kyu, Seo Jeonghun, et al. Pulmonary extraintestinal manifestation of crohn′s disease treated successfully with adalimumab[J]. Korean J Gastroenterol, 2018, 72(3): 141-145.
|
| 21 |
Greuter T, Bertoldo F, Rechner R, et al. Swiss IBD cohort study group extraintestinal manifestations of pediatric inflammatory bowel disease: prevalence, presentation, and anti-TNF treatment[J]. J Pediatr Gastroenterol Nutr, 2017, 65(2): 200-206.
|
| 22 |
Black H, Mendoza M, Murin S. Thoracic manifestations of inflammatory bowel disease[J]. Chest, 2007, 131: 524-532.
|
| 23 |
Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study[J]. Gastroenterology, 2005, 129: 827-836.
|
| 24 |
Click B, Anderson AM, Koutroubakis IE, et al. Peripheral eosinophilia in patients with inflammatory bowel disease defines an aggressive disease phenotype[J]. Am J Gastroenterol, 2017, 112(12): 1849-1858.
|
| 25 |
Papanikolaou I, Kagouridis K, Papiris SA. Patterns of airway involvement in inflammatory bowel diseases[J]. World J Gastrointest Pathophysiol, 2014, 5(4): 560-569.
|
| 26 |
Casey MB, Tazelaar HD, Myers JL, et al. Noninfectious lung pathology in patients with Crohn′s disease[J]. Am J Surg Pathol, 2003, 27: 213-219.
|
| 27 |
Harbord M, Annese V, Vavricka SR, et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease[J]. J Crohns Colitis, 2016, 10(3): 239-254.
|
| 28 |
Huang PH, Kuo CJ, Lin CW, et al. Mesalazine-related lung disease in a patient with ulcerative colitis[J]. Medicine, 2018, 97(48): 13242-13246.
|
| 29 |
刘 婕，吴碧芳，谢 韵，等. 炎症性肠病相关肺损伤的研究进展[J]. 中华炎性肠病杂志，2020, 4(3): 248-252.
|
| 30 |
Park Soo-Kyung, Wong Zhiqin, Park Sang Hyoung, et al. Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational study[J]. Dig Liver Dis, 2021, 53(2): 196-201.
|